A Florida company trying to make the practice of pill splitting safer and easier has raised at least $1 million in its latest round of funding.
According to a Form D filing, Accu-Break Pharmaceuticals Inc. could continue raising up to $1.5 million in equity, debt and other securities. The company’s vice president of business didn’t reply to an email request for comment, but it was noted in the filing that proceeds would be used for general expenses and R&D.
Accu-Break is the developer of technologies that enable oral drug tablets to be subdivided into smaller doses. Its proprietary technologies involve use of a drug-free break layer inside of tablets.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The company seeks licensing agreements with pharmaceutical companies. Last year, it signed a licensing deal with New Delhi’s Alembic Pharmaceuticals Ltd , which said it would launch five generic drugs over two to three years using the technology.
The FDA generally advises against pill splitting unless it’s specified in a drug’s labeling, because it may result in inaccurate or inconsistent doses. But it’s commonly done in an effort to save money or make them easier to swallow.
[Pill bottle courtesy of flickr user prudencebrown21]
